Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yen-Lin Chen

Showing results (301-310 of 341) with videos related to

Pageof 35
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation OncologistsElizabeth H Baldini, Ross A Abrams, Walter Bosch, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 15, 2022
The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature reviewPo-Jen Hsiao, Kun-Lin Wu, Yeu-Chin Chen, et al.
JCI Insight|April 4, 2023
Polarized localization of phosphatidylserine in the endothelium regulates Kir2.1Claire A Ruddiman, Richard Peckham, Melissa A Luse, et al.
Advances in Radiation Oncology|July 26, 2017
Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomasThomas F DeLaney, Yen-Lin Chen, Elizabeth H Baldini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2023
The Polyanionic Drug Suramin Neutralizes Histones and Prevents EndotheliopathyNuria Villalba, Adrian M Sackheim, Michael A Lawson, et al.
Cell Death Discovery|March 2, 2025
NDUFB7 mutations cause brain neuronal defects, lactic acidosis, and mitochondrial dysfunction in humans and zebrafishYen-Lin Chen, Brian Hon-Yin Chung, Masakazu Mimaki, et al.
Journal of Surgical Oncology|October 30, 2016
Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomasKaren De Amorim Bernstein, Norbert Liebsch, Yen-Lin Chen, et al.
Journal of Surgical Oncology|April 23, 2014
Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomasThomas F DeLaney, Norbert J Liebsch, Frank X Pedlow, et al.
Annals of Surgical Oncology|September 12, 2012
Desmoid tumor: analysis of prognostic factors and outcomes in a surgical seriesJohn T Mullen, Thomas F Delaney, Wendy K Kobayashi, et al.
Annals of Surgical Oncology|November 9, 2021
Assessing the Safety and Utility of Wound VAC Temporization of the Sarcoma or Benign Aggressive Tumor Bed Until Final Margins Are AchievedMitchell S Fourman, Duncan C Ramsey, Erik T Newman, et al.
Pageof 35

Showing results (301-310 of 341) with videos related to

Sort By:
Pageof 35
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation OncologistsElizabeth H Baldini, Ross A Abrams, Walter Bosch, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 15, 2022
The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature reviewPo-Jen Hsiao, Kun-Lin Wu, Yeu-Chin Chen, et al.
JCI Insight|April 4, 2023
Polarized localization of phosphatidylserine in the endothelium regulates Kir2.1Claire A Ruddiman, Richard Peckham, Melissa A Luse, et al.
Advances in Radiation Oncology|July 26, 2017
Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomasThomas F DeLaney, Yen-Lin Chen, Elizabeth H Baldini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2023
The Polyanionic Drug Suramin Neutralizes Histones and Prevents EndotheliopathyNuria Villalba, Adrian M Sackheim, Michael A Lawson, et al.
Cell Death Discovery|March 2, 2025
NDUFB7 mutations cause brain neuronal defects, lactic acidosis, and mitochondrial dysfunction in humans and zebrafishYen-Lin Chen, Brian Hon-Yin Chung, Masakazu Mimaki, et al.
Journal of Surgical Oncology|October 30, 2016
Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomasKaren De Amorim Bernstein, Norbert Liebsch, Yen-Lin Chen, et al.
Journal of Surgical Oncology|April 23, 2014
Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomasThomas F DeLaney, Norbert J Liebsch, Frank X Pedlow, et al.
Annals of Surgical Oncology|September 12, 2012
Desmoid tumor: analysis of prognostic factors and outcomes in a surgical seriesJohn T Mullen, Thomas F Delaney, Wendy K Kobayashi, et al.
Annals of Surgical Oncology|November 9, 2021
Assessing the Safety and Utility of Wound VAC Temporization of the Sarcoma or Benign Aggressive Tumor Bed Until Final Margins Are AchievedMitchell S Fourman, Duncan C Ramsey, Erik T Newman, et al.
Pageof 35